Medical devices, healthcare technology and the business of care
510(k) clearance · K262769

Permatage XT Settable Nonabsorbable Hemostatic Bone Putty (OS-PER-1001XT)

Orthocon, Inc. · Decision date Sep 3, 2026

MEDTECHLEDGER EXPLANATIONK262769

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 2026-09-03 for Permatage XT Settable Nonabsorbable Hemostatic Bone Putty (OS-PER-1001XT), submitted by Orthocon, Inc. of Stamford, Connecticut, under 510(k) number K262769. The device falls under classification name Wax, Bone, product code MTJ, with the Orthopedic review panel listed; the application was received 08/04/2026. A SESE decision is a 510(k) clearance, not a PMA approval.

The public record identifies the device as a settable, nonabsorbable hemostatic bone putty but does not describe its components, materials, or any changed item, and no predicate device is named in the available text. The summary is listed as type Special and the record states the submission was not reviewed by a third party, was not a combination product, and had no authorized predetermined change control plan. The specialty field is recorded as Unknown, and clinical performance data, indications, and use instructions are not available here; those would reside in the linked FDA summary document.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Unknown
Decision date
Sep 3, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262769
Regulatory pathway
510(k) premarket notification
Product code
MTJ
Decision code
SESE
Decision date
Sep 3, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Wax, Bone.

Product code
MTJ
FDA device class
U

FDA decision timeline

  1. K262769 received

    Application receipt date recorded by FDA.

  2. K262769 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Orthocon, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Stamford, CT

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records